CORPORATE OVERVIEW Founded in 2007, Alizé Pharma is a group of privately held biopharmaceutical companies specialized in the development of innovative biopharmaceutical drugs, proteins and peptides, for the treatment of metabolic diseases and rare diseases. It is based in Ecully, near Lyon, France. Its management is made up of a team of drug development experts and a board of directors offering wide international experience. Business Model The group acquires R&D programs from public or private laboratories, following strict selection criteria, with particular interest in medical needs and innovation. Alizé Pharma operates preclinical and clinical development, then establishing partnerships with the pharmaceutical industry via co-development or out-licensing agreements, in order to secure both near-term and long-term revenue streams. Alizé Pharma considers its most important value add to be the expertise of its team who is highly experienced in drug development and able to bring many years of successful experience in this field.

For more information,visit www.alz-pharma.com.